Skip to content

MaxCyte MXCT Income Tax

Income Tax at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$162.7M-939%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$70M-26.3%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$80K-191%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$11.27K+4.5%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$8K+14.3%
PDE
Pro-Dex, Inc.PDEX
$1.4M+9.6%

Other financials

Income statement

See full
Revenue$9.7M-7.1%
Gross profit$8.1M-9.1%
Operating income-$6.2M+49.7%
Net income-$4.8M+53.7%
EPS (diluted)-$0.04+60.0%

Balance sheet

See full
Cash & equivalents$14.6M-37.8%
Total debt$17.5M-7.1%
Total equity$167.9M-15.8%
Total assets$194.5M-15.4%

Cash flow

See full
Operating cash flow-$8.2M+43.3%
CapEx$72.0K-89.0%
Free cash flow-$8.2M+45.3%

Valuation

See full
Market cap$130.15M-46.8%
Enterprise value$133.08M-46.3%
P/S-2.8×

Profitability

See full
Gross margin80.5%-0.4pp
Operating margin-141.8%+6.4pp
Net margin-121.2%+12.3pp
FCF margin-90.9%+3.7pp

Returns & leverage

See full
Return on equity-21.3%+2.0pp
Debt / equity0.1×0.0×
Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: MaxCyte’s 10-K, filed March 22, 2022, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxCyte's income tax?
MaxCyte (MXCT) reported income tax of $0 in Q4 2021.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.